These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14678609)

  • 21. [Peptide mapping of H-2d restricted T-cell epitope against six antigens of HIV-1 subtype B'/C by ELISPOT assay].
    Qi XR; Gao YY; Lu RJ; Deng Y; Meng X; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 Jan; 27(1):34-43. PubMed ID: 21462504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA class I binding regions of HIV-1 proteins.
    Choppin J; Guillet JG; Lévy JP
    Crit Rev Immunol; 1992; 12(1-2):1-16. PubMed ID: 1384546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
    Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.
    Sharp ER; Barbour JD; Karlsson RK; Jordan KA; Sandberg JK; Wiznia A; Rosenberg MG; Nixon DF
    J Infect Dis; 2005 Nov; 192(10):1772-80. PubMed ID: 16235176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host-specific adaptation of HIV-1 subtype B in the Japanese population.
    Chikata T; Carlson JM; Tamura Y; Borghan MA; Naruto T; Hashimoto M; Murakoshi H; Le AQ; Mallal S; John M; Gatanaga H; Oka S; Brumme ZL; Takiguchi M
    J Virol; 2014 May; 88(9):4764-75. PubMed ID: 24522911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag.
    Semeniuk CA; McKinnon L; Peters HO; Gubbins M; Mao X; Ball TB; Luo M; Plummer FA
    AIDS; 2009 Apr; 23(7):771-7. PubMed ID: 19287301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.
    Luo M; Daniuk CA; Diallo TO; Capina RE; Kimani J; Wachihi C; Kimani M; Bielawny T; Peterson T; Mendoza MG; Kiazyk S; Ball TB; Plummer FA
    J Virol; 2012 Jan; 86(2):1166-80. PubMed ID: 22072744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Subtype C gag-specific T-cell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians.
    Tsegaye A; Ran L; Wolday D; Petros B; Dorigo W; Piriou E; Messele T; Sanders E; Tilahun T; Eshetu D; Schuitemaker H; Coutinho RA; Miedema F; Borghans J; van Baarle D
    J Acquir Immune Defic Syndr; 2007 Aug; 45(4):389-400. PubMed ID: 17417101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
    Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
    PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.
    Soto-Nava M; Avila-Ríos S; Valenzuela-Ponce H; García-Morales C; Carlson JM; Tapia-Trejo D; Garrido-Rodriguez D; Alva-Hernández SN; García-Tellez TA; Murakami-Ogasawara A; ; Mallal SA; John M; Brockman MA; Brumme CJ; Brumme ZL; Reyes-Teran G;
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.
    Almeida CA; Bronke C; Roberts SG; McKinnon E; Keane NM; Chopra A; Kadie C; Carlson J; Haas DW; Riddler SA; Haubrich R; Heckerman D; Mallal S; John M
    J Immunol; 2011 Sep; 187(5):2502-13. PubMed ID: 21821798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell recognition of HIV synthetic peptides in a natural infection.
    Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
    J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.
    Wilson CC; Palmer B; Southwood S; Sidney J; Higashimoto Y; Appella E; Chesnut R; Sette A; Livingston BD
    J Virol; 2001 May; 75(9):4195-207. PubMed ID: 11287569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure.
    Ngumbela KC; Day CL; Mncube Z; Nair K; Ramduth D; Thobakgale C; Moodley E; Reddy S; de Pierres C; Mkhwanazi N; Bishop K; van der Stok M; Ismail N; Honeyborne I; Crawford H; Kavanagh DG; Rousseau C; Nickle D; Mullins J; Heckerman D; Korber B; Coovadia H; Kiepiela P; Goulder PJ; Walker BD
    AIDS Res Hum Retroviruses; 2008 Jan; 24(1):72-82. PubMed ID: 18275350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-Reactive Potential of HIV-1 Subtype C-Infected Indian Individuals Against Multiple HIV-1 Potential T Cell Epitope Gag Variants.
    Negi N; Vajpayee M; Singh R; Sharma A; Murugavel KG; Ranga U; Thakar M; Sreenivas V; Das BK
    Viral Immunol; 2016 Dec; 29(10):572-582. PubMed ID: 27875663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    Cao J; McNevin J; Holte S; Fink L; Corey L; McElrath MJ
    J Virol; 2003 Jun; 77(12):6867-78. PubMed ID: 12768006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Egan MA; Kuroda MJ; Voss G; Schmitz JE; Charini WA; Lord CI; Forman MA; Letvin NL
    J Virol; 1999 Jul; 73(7):5466-72. PubMed ID: 10364294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.